肛门癌临床实践指南 2018 年版 NCCN 肿瘤学
Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
出版信息
J Natl Compr Canc Netw. 2018 Jul;16(7):852-871. doi: 10.6004/jnccn.2018.0060.
Abstract
The NCCN Guidelines for Anal Carcinoma provide recommendations for the management of patients with squamous cell carcinoma of the anal canal or perianal region. Primary treatment of anal cancer usually includes chemoradiation, although certain lesions can be treated with margin-negative local excision alone. Disease surveillance is recommended for all patients with anal carcinoma because additional curative-intent treatment is possible. A multidisciplinary approach including physicians from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology is essential for optimal patient care.
摘要
NCCN 肛门癌临床实践指南为肛管或肛门周围鳞状细胞癌患者的管理提供了建议。肛门癌的主要治疗方法通常包括放化疗，尽管某些病变可以单独采用切缘阴性的局部切除术治疗。推荐对所有肛门癌患者进行疾病监测，因为可能需要进行额外的治愈性治疗。包括胃肠病学、肿瘤内科、肿瘤外科、放射肿瘤学和放射科医生在内的多学科方法对于患者的最佳护理至关重要。
相似文献
1
Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.肛门癌临床实践指南 2018 年版 NCCN 肿瘤学
J Natl Compr Canc Netw. 2018 Jul;16(7):852-871. doi: 10.6004/jnccn.2018.0060.
2
Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.直肠癌临床实践指南（NCCN 肿瘤学版）2018 年第 2 版
J Natl Compr Canc Netw. 2018 Jul;16(7):874-901. doi: 10.6004/jnccn.2018.0061.
3
Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial.ACT II 试验中，在接受丝裂霉素 C 或顺铂放化疗联合或不联合维持化疗的肛门鳞癌患者中，肿瘤和治疗相关的结肠造口率。
Ann Oncol. 2014 Aug;25(8):1616-22. doi: 10.1093/annonc/mdu188. Epub 2014 May 14.
4
Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.肛门癌临床实践指南（2023 年版），NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2023 Jun;21(6):653-677. doi: 10.6004/jnccn.2023.0030.
5
Outcomes after intensity-modulated compared with 3-dimensional conformal radiotherapy with chemotherapy for squamous cell carcinoma of the anal canal.调强放疗与化疗联合 3 维适形放疗治疗肛管鳞癌的疗效比较。
Curr Oncol. 2019 Aug;26(4):e515-e521. doi: 10.3747/co.26.4311. Epub 2019 Aug 1.
6
Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal.卡培他滨替代5-氟尿嘧啶用于肛管局部鳞状细胞癌患者放化疗方案的II期研究
J Gastrointest Cancer. 2016 Mar;47(1):75-81. doi: 10.1007/s12029-015-9790-4.
7
Review of anal cancer patients at the Ottawa hospital.渥太华医院对肛管癌患者的回顾。
Eur J Surg Oncol. 2015 May;41(5):653-8. doi: 10.1016/j.ejso.2015.02.004. Epub 2015 Mar 4.
8
Pencil Beam Scanning Proton Beam Chemoradiation Therapy With 5-Fluorouracil and Mitomycin-C for Definitive Treatment of Carcinoma of the Anal Canal: A Multi-institutional Pilot Feasibility Study.铅笔束扫描质子束放化疗联合氟尿嘧啶和丝裂霉素 C 治疗肛管癌的多中心可行性研究。
Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):90-95. doi: 10.1016/j.ijrobp.2019.04.040. Epub 2019 May 22.
9
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.欧洲多学科指南：侵袭性鳞状细胞皮肤癌 第 2 部分：治疗。
Eur J Cancer. 2020 Mar;128:83-102. doi: 10.1016/j.ejca.2020.01.008. Epub 2020 Feb 26.
10
Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.外阴癌临床实践指南（2017 年第 1 版），NCCN 肿瘤学临床实践指南
J Natl Compr Canc Netw. 2017 Jan;15(1):92-120. doi: 10.6004/jnccn.2017.0008.
引用本文的文献
1
Incremental value of extracellular volume fraction based on CT for microsatellite status in colorectal cancer.基于CT的细胞外容积分数对结直肠癌微卫星状态的增量价值。
Jpn J Radiol. 2025 Jul 4. doi: 10.1007/s11604-025-01825-2.
2
Anal and Perianal Masses: The Common, the Uncommon, and the Rare.肛门及肛管周围肿物：常见、不常见及罕见情况
Indian J Radiol Imaging. 2024 Mar 23;34(4):688-701. doi: 10.1055/s-0044-1781459. eCollection 2024 Oct.
3
Immunological Checkpoint Blockade in Anal Squamous Cell Carcinoma: Dramatic Responses Tempered By Frequent Resistance.免疫检查点阻断在肛门鳞状细胞癌中的应用：频繁耐药导致戏剧性反应受到抑制。
Curr Oncol Rep. 2024 Aug;26(8):967-976. doi: 10.1007/s11912-024-01564-z. Epub 2024 Jun 11.
4
Local excision versus radical surgery for anal squamous cell carcinoma: a multicenter study in Japan.局部切除与根治性手术治疗肛门鳞状细胞癌：日本多中心研究。
Int J Clin Oncol. 2024 Jun;29(6):813-821. doi: 10.1007/s10147-024-02498-z. Epub 2024 Mar 25.
5
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders.帕博利珠单抗治疗晚期肛门鳞状细胞癌疗效的生物标志物：一项II期临床试验及长期缓解者队列分析
J Immunother Cancer. 2024 Jan 25;12(1):e008436. doi: 10.1136/jitc-2023-008436.
6
Targeting survivin with Tanshinone IIA inhibits tumor growth and overcomes chemoresistance in colorectal cancer.丹参酮IIA靶向Survivin抑制结直肠癌肿瘤生长并克服化疗耐药性。
Cell Death Discov. 2023 Sep 25;9(1):351. doi: 10.1038/s41420-023-01622-8.
7
An Updated Review on Imaging and Staging of Anal Cancer-Not Just Rectal Cancer.肛门癌的影像学和分期更新：不只是直肠癌。
Tomography. 2023 Sep 4;9(5):1694-1710. doi: 10.3390/tomography9050135.
8
Clinicopathological Characteristics and Outcomes of Anal Squamous Cell Carcinoma Patients With and Without HIV Infection in Sub-Saharan Africa.撒哈拉以南非洲地区有和无 HIV 感染的肛门鳞癌患者的临床病理特征和结局。
JCO Glob Oncol. 2023 May;9:e2200394. doi: 10.1200/GO.22.00394.
9
PET/MRI in colorectal and anal cancers: an update.正电子发射断层扫描/磁共振成像（PET/MRI）在结直肠癌和肛门癌中的应用：更新。
Abdom Radiol (NY). 2023 Dec;48(12):3558-3583. doi: 10.1007/s00261-023-03897-y. Epub 2023 Apr 16.
10
Impact of glucocorticoids on the efficacy of neoadjuvant chemoradiotherapy and survival of patients with locally advanced rectal cancer: a retrospective study.糖皮质激素对局部晚期直肠癌新辅助放化疗疗效和患者生存的影响：一项回顾性研究。
BMC Cancer. 2023 Mar 14;23(1):238. doi: 10.1186/s12885-023-10592-0.
本文引用的文献
1
Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers.胃肠道癌大患者队列中肿瘤突变负荷、错配修复缺陷和 PD-L1 表达的全景。
Mol Cancer Res. 2018 May;16(5):805-812. doi: 10.1158/1541-7786.MCR-17-0735. Epub 2018 Mar 9.
2
Cancer statistics, 2018.癌症统计数据，2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
3
Anal Cancer Risk Among People With HIV Infection in the United States.美国 HIV 感染者的肛门癌风险。
J Clin Oncol. 2018 Jan 1;36(1):68-75. doi: 10.1200/JCO.2017.74.9291. Epub 2017 Nov 15.
4
Management of Stage I Squamous Cell Carcinoma of the Anal Canal.肛管Ⅰ期鳞状细胞癌的治疗。
JAMA Surg. 2018 Mar 1;153(3):209-215. doi: 10.1001/jamasurg.2017.3151.
5
Impact of Intensity-Modulated Radiotherapy on Health Care Costs of Patients With Anal Squamous Cell Carcinoma.调强放疗对肛门鳞癌患者医疗费用的影响。
J Oncol Pract. 2017 Dec;13(12):e992-e1001. doi: 10.1200/JOP.2017.024810. Epub 2017 Oct 16.
6
Association of HIV Status With Outcomes of Anal Squamous Cell Carcinoma in the Era of Highly Active Antiretroviral Therapy.高效抗逆转录病毒治疗时代人类免疫缺陷病毒状况与肛门鳞状细胞癌结局的关联。
JAMA Oncol. 2018 Jan 1;4(1):120-122. doi: 10.1001/jamaoncol.2017.2844.
7
PET imaging in anal canal cancer: a systematic review and meta-analysis.肛管癌的正电子发射断层显像：一项系统评价与荟萃分析
Br J Radiol. 2017 Dec;90(1080):20170370. doi: 10.1259/bjr.20170370. Epub 2017 Oct 3.
8
Prognostic and Predictive Clinicopathologic Factors of Squamous Anal Canal Cancer in HIV-Positive and HIV-Negative Patients: Does HAART Influence Outcomes?HIV阳性和HIV阴性患者肛管鳞癌的预后及预测性临床病理因素：高效抗逆转录病毒治疗（HAART）对预后有影响吗？
World J Surg. 2018 Mar;42(3):876-883. doi: 10.1007/s00268-017-4201-6.
9
Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.1996 年至 2012 年美国 HIV 感染者的癌症风险：基于人群的登记关联研究。
Lancet HIV. 2017 Nov;4(11):e495-e504. doi: 10.1016/S2352-3018(17)30125-X. Epub 2017 Aug 10.
10
Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study.肛门癌的淋巴结分期转移与预后：系统评价、荟萃回归和模拟研究。
Lancet Oncol. 2017 Oct;18(10):1348-1359. doi: 10.1016/S1470-2045(17)30456-4. Epub 2017 Aug 9.
Zotero 插件